Nothing Special   »   [go: up one dir, main page]

CN109797189A - A kind of identification of target cell and killing method - Google Patents

A kind of identification of target cell and killing method Download PDF

Info

Publication number
CN109797189A
CN109797189A CN201910027891.2A CN201910027891A CN109797189A CN 109797189 A CN109797189 A CN 109797189A CN 201910027891 A CN201910027891 A CN 201910027891A CN 109797189 A CN109797189 A CN 109797189A
Authority
CN
China
Prior art keywords
cell
ctl
sample
target cell
nkg2d
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910027891.2A
Other languages
Chinese (zh)
Inventor
周双念
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Bike Biotechnology Co Ltd
Original Assignee
Shenzhen Bike Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Bike Biotechnology Co Ltd filed Critical Shenzhen Bike Biotechnology Co Ltd
Priority to CN201910027891.2A priority Critical patent/CN109797189A/en
Publication of CN109797189A publication Critical patent/CN109797189A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of identifications of target cell and killing method, comprising: cultivates the NK cell with high expression NKg2d;Cultivate the CTL cell with high activity;NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, under its microenvironment, the part NKg2d of NK cell secretion is entrenched in CTL cell surface of the same race, restore the identification and killing ability of CTL cell, CTL cell is realized to the target cell identification of the MHC-1 class molecule positive, killing and is removed, the restricted feature of non-MHC-1 for applying NK cell simultaneously, is identified, killed and is removed to the target cell of non-MHC-1 class molecule feminine gender.

Description

A kind of identification of target cell and killing method
Technical field
The present invention relates to cell field more particularly to a kind of identifications of target cell and killing method.
Background technique
There are in the sample of abnormal target cell, the identification receptor NKg2d of CTL cell surface, which is easy to fall off, causes it to exception The recognition performance of target cell declines, it is difficult to kill the abnormal target cell of low expression MHC-1 class molecule.
Summary of the invention
For overcome the deficiencies in the prior art, the purpose of the present invention is to provide a kind of identifications of target cell and killing side Method, to identify and kill abnormal target cell.
The purpose of the present invention adopts the following technical scheme that realization:
A kind of identification of target cell and killing method, comprising:
Cultivate the NK cell with high expression NKg2d;
Cultivate the CTL cell with high activity;
NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, so that Part NKg2d is adhered to the CTL cell.
Further, it cultivates before there is the high NK cell for expressing NKg2d further include:
NK cell sample and CTL cell sample are extracted from sample.
Further, after extracting NK cell sample and CTL cell sample in sample further include:
The NK cell sample and the CTL cell sample are separated, cultivated and expanded.
Compared with prior art, the beneficial effects of the present invention are: by the NK cell with high expression NKg2d and have high living Property CTL cell inject abnormal target cell sample so that part NKg2d is adhered to CTL cell, to make the release of CTL cell Granzyme, lysosome, perforin, Fas, IFN etc., realize CTL cell to the identification of the target cell of MHC-1 class molecule positive, kill and It removes, while the restricted feature of non-MHC-1 of application NK cell, the target cell of non-MHC-1 class molecule feminine gender is identified, is killed Wound and removing.
Detailed description of the invention
Fig. 1 is the identification and killing method of target cell provided in an embodiment of the present invention.
Specific embodiment
In the following, being described further in conjunction with attached drawing and specific embodiment to the present invention, it should be noted that not Under the premise of conflicting, new implementation can be formed between various embodiments described below or between each technical characteristic in any combination Example.
As shown in Figure 1, the identification of target cell provided in an embodiment of the present invention and killing method, comprising:
Step S101: the NK cell with high expression NKg2d is cultivated.
Preferably, extracting NK cell sample and CTL cell sample from sample, wherein sample before cultivating NK cell Same main body is come from target cell, NK cell normal expression NKg2d, the CTL cell surface in sample has NKg2d.Extract NK After cell sample and CTL cell sample, NK cell sample and the CTL cell sample are separated, cultivated and expanded, is passed through Existing breeding method cultivates the NK cell of high expression NKg2d.
Step S102: the CTL cell with high activity is cultivated.
Specifically, cultivating the CTL cell of high activity so that CTL cell is effectively combined with NKg2d.
Step S103: the NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell Sample, so that part NKg2d is adhered to the CTL cell.
Specifically, abnormal target cell is easily parasitic or is gathered in solid tissue or organ, the CTL in abnormal target cell sample is thin The decline of born of the same parents' performance, the NKg2d on surface fall off, and cannot kill mutant.By the NK cell with high expression NKg2d and there is height Active CTL cell successively injects abnormal target cell sample, in abnormal target cell sample environment, the part of NK cell secretion NKg2d adaptively carries or is embedded in automatically CTL cell surface of the same race, to improve CTL cell to the identification energy of abnormal target cell Power, while granzyme is discharged, lysosome, perforin, Fas, IFN etc., using the targeting of CTL cell to MHC-1 class molecule sun Property target cell identification, killing and remove;The restricted feature of non-MHC-1 for utilizing NK cell simultaneously, to non-MHC-1 class molecule yin Property target cell identified, killed and removed, to the identification of the target cell of different type and property, killing and remove.
The identification and killing method of target cell provided by the invention by the NK cell with high expression NKg2d and have height Active CTL cell injects abnormal target cell sample, so that part NKg2d is adhered to CTL cell, restores the identification of CTL cell With killing ability, to make CTL cell released both particle enzyme, lysosome, perforin, Fas, IFN etc. realize CTL cell to MHC-1 Target cell identification, killing and the removing of the class molecule positive, while the restricted feature of non-MHC-1 of application NK cell, to non-MHC-1 The target cell of class molecule feminine gender is identified, killed and is removed.
The above embodiment is only the preferred embodiment of the present invention, and the scope of protection of the present invention is not limited thereto, The variation and replacement for any unsubstantiality that those skilled in the art is done on the basis of the present invention belong to institute of the present invention Claimed range.

Claims (3)

1. a kind of identification of target cell and killing method characterized by comprising
Cultivate the NK cell with high expression NKg2d;
Cultivate the CTL cell with high activity;
NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, so that part NKg2d is adhered to the CTL cell surface.
2. the identification of target cell according to claim 1 and killing method, which is characterized in that cultivating has high expression Before the NK cell of NKg2d further include:
NK cell sample and CTL cell sample are extracted from sample.
3. the identification of target cell according to claim 2 and killing method, which is characterized in that it is thin to isolate NK from sample After born of the same parents' sample and CTL cell sample further include:
The NK cell sample and the CTL cell sample are separated, cultivated and expanded.
CN201910027891.2A 2019-01-11 2019-01-11 A kind of identification of target cell and killing method Pending CN109797189A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910027891.2A CN109797189A (en) 2019-01-11 2019-01-11 A kind of identification of target cell and killing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910027891.2A CN109797189A (en) 2019-01-11 2019-01-11 A kind of identification of target cell and killing method

Publications (1)

Publication Number Publication Date
CN109797189A true CN109797189A (en) 2019-05-24

Family

ID=66557074

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910027891.2A Pending CN109797189A (en) 2019-01-11 2019-01-11 A kind of identification of target cell and killing method

Country Status (1)

Country Link
CN (1) CN109797189A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068141A1 (en) * 2006-03-06 2009-03-12 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer
CN101495864A (en) * 2006-04-12 2009-07-29 硅生物系统股份公司 Diagnostic and therapeutic application of CTL and NK functionally selected cells
CN103800898A (en) * 2014-03-13 2014-05-21 蔡颖 Tumor specific killer cell preparation and preparation method thereof
US20140377266A1 (en) * 2011-09-09 2014-12-25 Fred Hutchinson Cancer Research Center Methods and Compositions Involving NKG2D Inhibitors and Cancer
CN106011060A (en) * 2016-06-29 2016-10-12 北京中台恒基生物技术有限公司 In-vitro activation and amplification method of NKT-like cells
CN109071679A (en) * 2016-02-05 2018-12-21 华盛顿大学 The composition and method that cell factor for targeting delivers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068141A1 (en) * 2006-03-06 2009-03-12 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer
CN101495864A (en) * 2006-04-12 2009-07-29 硅生物系统股份公司 Diagnostic and therapeutic application of CTL and NK functionally selected cells
US20140377266A1 (en) * 2011-09-09 2014-12-25 Fred Hutchinson Cancer Research Center Methods and Compositions Involving NKG2D Inhibitors and Cancer
CN103800898A (en) * 2014-03-13 2014-05-21 蔡颖 Tumor specific killer cell preparation and preparation method thereof
CN109071679A (en) * 2016-02-05 2018-12-21 华盛顿大学 The composition and method that cell factor for targeting delivers
CN106011060A (en) * 2016-06-29 2016-10-12 北京中台恒基生物技术有限公司 In-vitro activation and amplification method of NKT-like cells

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease" *
MARKIEWICZ MA等: "Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation" *
周双念: "自体双活化靶向免疫技术系统(NKg2d-CTL)的临床应用研究" *
曾小辉: "原发性肝癌外周血NK细胞受体NKG2D表达和NK细胞亚群分布的变化及意义" *

Similar Documents

Publication Publication Date Title
CN110037979B (en) Sheep mesenchymal stem cell-containing exosome freeze-dried powder and preparation method thereof
CN101608174A (en) A kind of construction process of human umbilical cord mesenchyma stem cell
CN105238736B (en) A kind of cultural method of dendrobium candidum stem cell and its application
WO2006052925A3 (en) Cardiac stem cells
IL160090A0 (en) Device for and method of controlled enzymatic removal and retrieval of tissue
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
WO2012170340A3 (en) Insertable neural probe with flexible structure
CN103393585B (en) Fibroblast liquid for beauty treatment and preparation method thereof
US10368980B2 (en) Middle ear mucosa-like cell sheet, process of producing the same and method of using the same
CN104814980A (en) Production method and applications of human embryo fibroblasts
JP2008526318A5 (en)
CN102965338A (en) Extraction and culture method of human umbilical cord mesenchymal stem cells
CN104450606B (en) Sweat gland cells inducing culture and its application
AU2015274627A1 (en) Inhibiting or reducing fungal infections
CN109797189A (en) A kind of identification of target cell and killing method
Kishta et al. Mesenchymal stem cells seeded onto nanofiber scaffold for myocardial regeneration
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
CN109320591A (en) A kind of polypeptide OA-GL12 and its application
CN104399122A (en) Acellular matrix and preparation method thereof
WO2020143043A1 (en) Method for identifying and killing target cell
CN102747137B (en) Identifying method for sunflower phoma black stem bacteria
CN104911142B (en) A kind of in vitro separation and culture method and application of deer corium hair papilla cell
CN113332313A (en) Stem cell preparation for treating seborrheic alopecia
CN107661569A (en) One kind is used for the oxidation resistant stem cell processed material micropin of skin
CN109097321A (en) A kind of primary separation method of hair follicle stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination